Literature DB >> 23688217

Association of serum dehydroepiandrosterone sulfate and cognition in older adults: sex steroid, inflammatory, and metabolic mechanisms.

Kerry L Hildreth1, Wendolyn S Gozansky2, Catherine M Jankowski1, Jim Grigsby1, Pamela Wolfe3, Wendy M Kohrt1.   

Abstract

OBJECTIVE: Dehydroepiandrosterone sulfate (DHEAS) levels and cognitive function decline with age, and a role for DHEAS in supporting cognition has been proposed. Higher DHEAS levels may be associated with better cognitive performance, although potential mechanisms for this relationship are not well established.
METHOD: We performed a cross-sectional study of the relationship between serum DHEAS and three aspects of cognition--executive function, working memory, and processing speed--in 49 men and 54 women, aged 60-88 years, with low serum DHEAS levels. We examined three potential mechanisms of DHEAS action--sex hormone sufficiency, inflammatory status, and glucose regulation.
RESULTS: After adjustment for multiple covariates, higher serum DHEAS levels were associated with better working memory (standardized beta coefficient 0.50, p < .05), with a trend toward better executive function (standardized beta coefficient 0.37, p < .10) in men only. There was a nonsignificant trend toward a negative association between levels of tumor necrosis factor α (TNFα) and working memory in the combined population (standardized beta coefficient -0.22, p < .10). None of the glucoregulatory measures was associated with cognitive function.
CONCLUSIONS: The relationship between DHEAS and cognition is complex and differs by sex and cognitive domain. This study supports the need for further investigations of the sex-specific effects of DHEAS on cognition and its underlying mechanisms of action.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23688217      PMCID: PMC4316210          DOI: 10.1037/a0032230

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  45 in total

Review 1.  Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance.

Authors:  M D Majewska
Journal:  Prog Neurobiol       Date:  1992       Impact factor: 11.685

2.  Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative.

Authors:  R A Daynes; B A Araneo; W B Ershler; C Maloney; G Z Li; S Y Ryu
Journal:  J Immunol       Date:  1993-06-15       Impact factor: 5.422

3.  Basal cortisol levels and cognitive deficits in human aging.

Authors:  S Lupien; A R Lecours; I Lussier; G Schwartz; N P Nair; M J Meaney
Journal:  J Neurosci       Date:  1994-05       Impact factor: 6.167

4.  Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men.

Authors:  S M Haffner; R A Valdez; L Mykkänen; M P Stern; M S Katz
Journal:  Metabolism       Date:  1994-05       Impact factor: 8.694

5.  Hyperinsulinemia and risk of Alzheimer disease.

Authors:  Jose A Luchsinger; Ming-Xin Tang; Steven Shea; Richard Mayeux
Journal:  Neurology       Date:  2004-10-12       Impact factor: 9.910

6.  A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: the Rancho Bernardo Study.

Authors:  E Barrett-Connor; S L Edelstein
Journal:  J Am Geriatr Soc       Date:  1994-04       Impact factor: 5.562

7.  Facilitation of hippocampal long-lasting potentiation by GABA antagonists.

Authors:  H Wigström; B Gustafsson
Journal:  Acta Physiol Scand       Date:  1985-09

8.  Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis.

Authors:  P N Sambrook; J A Eisman; G D Champion; N A Pocock
Journal:  Arthritis Rheum       Date:  1988-08

9.  Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in Alzheimer's disease patients and in Parkinson's disease patients.

Authors:  S Genedani; G Rasio; P Cortelli; F Antonelli; D Guidolin; M Galantucci; K Fuxe; L F Agnati
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

View more
  5 in total

1.  Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities.

Authors:  Shanna L Burke; Tianyan Hu; Nicole M Fava; Tan Li; Miriam J Rodriguez; Katie L Schuldiner; Aaron Burgess; Angela Laird
Journal:  J Women Aging       Date:  2018-01-10

2.  Hair cortisol and dehydroepiandrosterone concentrations: Associations with executive function in early childhood.

Authors:  Ella-Marie P Hennessey; Olga Kepinska; Stephanie L Haft; Megan Chan; Isabel Sunshine; Chloe Jones; Roeland Hancock; Fumiko Hoeft
Journal:  Biol Psychol       Date:  2020-08-14       Impact factor: 3.251

3.  Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy.

Authors:  Yi Long Toh; Juliana Shariq Mujtaba; Sumit Bansal; Angie Yeo; Maung Shwe; Aik Jiang Lau; Alexandre Chan
Journal:  Pharmacotherapy       Date:  2019-04-04       Impact factor: 4.705

Review 4.  Testosterone and Dehydroepiandrosterone Treatment in Ageing Men: Are We All Set?

Authors:  Andreas Walther; Julian Seuffert
Journal:  World J Mens Health       Date:  2019-06-04       Impact factor: 5.400

5.  Longitudinal evaluation of dehydroepiandrosterone (DHEA), its sulfated form and estradiol with cancer-related cognitive impairment in early-stage breast cancer patients receiving chemotherapy.

Authors:  Yi Long Toh; Chia Jie Tan; Ning Yi Yap; Ritesh Parajuli; Aik Jiang Lau; Alexandre Chan
Journal:  Sci Rep       Date:  2022-10-03       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.